DJIA 17,050.12 -71.89 -0.42%
NASDAQ 4,553.09 -16.53 -0.36%
S&P 500 1,993.84 -6.28 -0.31%
market minute promo

GlaxoSmithKline (NYSE: GSK)

company name or ticker
Company Photos
(Click to zoom)

Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom

What Will Puma Biotechnology Inc's $700 Million Man Do Next?

A sale to Johnson & Johnson, Pfizer, Roche, or one of the other big pharmas seems like the most likely outcome for Puma Biotechnology Inc.

Is Inovio Undervalued After Positive HPV Therapy Results?

GlaxoSmithKline's (GSK) CEO Andrew Wittyon Q2 2014 Results - Earnings Call Transcript

Wednesday's ETF with Unusual Volume: PPH

FDA Approves Gilead Sciences Drug for 3 Cancers

The company's tablet, Zydelig, works by blocking signals inside some cancer cells that allow them to grow and survive.

Why GlaxoSmithKline (GSK) Stock Continues To Sink Today

Glaxo Leads Declines Among European ADRs on Disappointing Earnings, Outlook

What To Buy: Top 3 Buy-Rated Dividend Stocks: STWD, ESV, GSK

Here's What You Need to Know About AbbVie and GlaxoSmithKline's Upcoming Earnings

AbbVie and GlaxoSmithKline are expected to report second quarter earnings this week. Here's what you need to know.